Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Rhythm Pharmaceuticals' Interest & Investment Income rose 675.88% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 194.46%. This contributed to the annual value of $14.7 million for FY2024, which is 549.3% up from last year.
  • Rhythm Pharmaceuticals' Interest & Investment Income amounted to $4.3 million in Q3 2025, which was up 675.88% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Interest & Investment Income registered a high of $4.3 million during Q3 2025, and its lowest value of $21000.0 during Q2 2021.
  • For the 5-year period, Rhythm Pharmaceuticals' Interest & Investment Income averaged around $2.4 million, with its median value being $3.2 million (2023).
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Interest & Investment Income crashed by 9737.83% in 2021 and then soared by 216940.3% in 2022.
  • Over the past 5 years, Rhythm Pharmaceuticals' Interest & Investment Income (Quarter) stood at $134000.0 in 2021, then soared by 2169.4% to $3.0 million in 2022, then increased by 25.58% to $3.8 million in 2023, then dropped by 7.96% to $3.5 million in 2024, then grew by 23.13% to $4.3 million in 2025.
  • Its Interest & Investment Income stands at $4.3 million for Q3 2025, versus $3.2 million for Q2 2025 and $3.6 million for Q1 2025.